Hansa Biopharma AB (Publ) (HNSBF) CEO Søren Tulstrup On Q3 2021 Results – Earnings Call Transcript

Hansa Biopharma AB (publ) (OTC:HNSBF) Q3 2021 Earnings Conference Call October 21, 2021 8:00 AM ET
Company Participants
Klaus Sindahl – Head of Investor Relations
Søren Tulstrup – President & Chief Executive Officer
Donato Spota – Chief Financial Officer

Click here to view the original article.